[1]
L. H. Dohn, B. V. Jensen, and F. O. Larsen, “Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer”, AO, vol. 49, no. 3, pp. 395–396, Jan. 2010.